Drug Treatment of Tricyclic Resistant Depression

References

• American Psychiatric Association. Task force on the use of laboratory tests in psychiatry. Tricyclicantidepressants—blood level measurements and clinical outcome: an APA Task Force report. American Journal of Psychiatry 1985; 142: 155–162
   PubMedGoogle Scholar
• Angst J., Woggon B., Schoepf J. The treatment of depression with 1-5-hydroxytryptophan versus imipramine. Archiv fur Psychiatric und Nervenkrankheiter 1977; 22(4)175–186
   Google Scholar
• Asberg M., Thosen P., Traskman L., Bertilsson L., Ringberger U. Serotonin depression: a biochemical subgroup within the affective disorders?. Science 1976; 191: 478–480
   PubMed Web of Science ®Google Scholar
• Ayd F. J., Zohar J. Psychostimulant (amphetamine or methylphenidate) therapy for chronic and treatment resistant depression. Treating Resistant Depression 1987; 343–355
   Google Scholar
• Ayd F. J. Treatment resistant depression: therapeutic strategies. Affective Disorders Reassessed, F. J. Ayd, I. J. Taylor, B. T. Taylor. Ayd Medical Communications, Baltimore 1983; 115–125
   Google Scholar
• Ayuso Guttierrez J. L., Loper-Ibor Linon J. J. Tryptophan and an MAOI (Nialamide) in the treatment of depression. A double blind study. International Pharmacopsychiatry 1971; 6: 92–97
   PubMedGoogle Scholar
• Barker W. A., Scott J., Eccleston D. The Newcastle Chronic Depression Study: Results of a treatment regime. International Clinical Psychopharmacology 1987; 2: 261–272
   PubMed Web of Science ®Google Scholar
• Barker W, Eccleston D. The treatment of chronic depression: an illustrative case. British Journal of Psychiatry 1984; 14(4)317–319
   Google Scholar
• Blier P., de Montigny C. Shortterm lithium administration enhances serotonergic neurotransmission: electrophysiological evidence in the rat CNS. European Journal of Pharmacology 1985; 11(3)69–77
   Google Scholar
• Burgess C. D. Therapeutic drug monitoring in psychiatry. Is it worthwhile?. Human Psychopharmacology 1986; 1: 83–87
   Google Scholar
• Charney D. S., Price L. H., Heninger G. R. Desipramine-yohimbine combination treatment for refractory depression. Archives of General Psychiatry 1986; 4(3)1155–1161
   Google Scholar
• Charney D. S., Nelson J. C. Delusional and non-delusional depression: further evidence for distinct subtypes. American Journal of Psychiatry 1981; 13(8)328–333
   Google Scholar
• Clinical Research Centre Division OF Psychiatry. The Northwick Park ECT Trial: predictors of response to oral and simulated ECT. British Journal of Psychiatry 1984; 144: 227–237
   PubMed Web of Science ®Google Scholar
• Cooper J. R., Bloom F. E., Roth R. H. The Biochemical Basis of Pharmacology. Oxford University Press, Oxford 1978
   Google Scholar
• Coppen A. J. The biochemistry of affective disorder. British Journal of Psychiatry 1967; 11(3)1237–1264
   Google Scholar
• Coppen A., Shaw D. M., Farrell J. P. Potentiation of the antidepressive effect of a monoamine oxidase inhibitor by tryptophan. Lancet 1963; i: 79–80
   Google Scholar
• Cowen P. J. Psychotropic drugs and human 5-HT neuroendocrinology. Trends in Pharmacological Sciences 1987; 8: 105–108
   Web of Science ®Google Scholar
• Cowen P. J., McCance S. L., Cohen P. R., Julier D. L. Lithium increases 5-HT-mediated neuroendocrine responses in tricyclic resistant depression. Psychopharmacology 1989; 9(9)230–232
   Google Scholar
• Crews F. T., Steven M. P., Goodwin F. K. Acceleration of β-receptor desensitization in combined administration of antidepressant and phenoxybenzamine. Nature 1981; 290: 787–789
   PubMed Web of Science ®Google Scholar
• Davidson J., McLeod M., Law-Yone B., Linnoila M. A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression. Archives of General Psychiatry 1978; 3(5)639–642
   Google Scholar
• Deleon-Jones F., Maas J. W., Dekirmenjian H., Sanchez J. Diagnostic subgroups of affective disorders and the urinary excretion of catecholamine metabolites. American Journal of Psychiatry 1973; 13(2)1141–1148
   Google Scholar
• de Montigny C., Aghajanian G. K. Tricyclic antidepressants: long term treatment increases responsivity of rat forebrain neurones to serotonin. Science 1978; 20(3)1303–1306
   Google Scholar
• de Montigny C., Grunberg F., Mayer A., Des-Chenes J. P. Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders. British Journal of Psychiatry 1981; 13(8)252–256
   Google Scholar
• de Montigny C., Elie R., Caille G. Rapid response to the addition of lithium in iprindole-resistant unipolar depression: a pilot study. American Journal of Psychiatry 1985; 14(2)220–223
   Google Scholar
• de Montigny C., Cournoyer G., Morissette R, et al. Lithium carbonate addition in tricyclic antide-pressant-resistant unipolar depression: correlations with the neurobiological actions of tricyclic drugs and lithium ion on the serotonin system. Archives of General Psychiatry 1983; 40: 1327–1334
   PubMed Web of Science ®Google Scholar
• Dinan T. G., Barry S. A comparison of electroconvulsive therapy with a lithium and tricyclic combination among depressed tricyclic non-responders. Acta Psychiatrica Scandinavica 1989; 80: 97–100
   PubMed Web of Science ®Google Scholar
• Earle B. V. Thyroid hormone and tricyclic antidepressants in resistant depressions. American Journal of Psychiatry 1970; 126: 1667–1669
   PubMed Web of Science ®Google Scholar
• Elphick M., Yang J. D., Cowen P. J. Effects of carbamazepine on dopamine and 5-HT-mediated neuroendocrine responses. Archives of General Psychiatry 1990; 4(7)135–140
   Google Scholar
• Fein S., Paz V., Rao N., Lagrassa J. The combination of lithium carbonate and an MAOI in refractory depressions. American Journal of Psychiatry 1988; 14(5)249–250
   Google Scholar
• Finch E. J.C., Katona C. L. E. Lithium augmentation in the treatment of refractory depression in old age. International Journal of Geriatric Psychiatry 1989; 4: 41–46
   Web of Science ®Google Scholar
• Gelder M. G., Gath D., Mayou R. Oxford Textbook of Psychiatry. Oxford University Press, Oxford 1983; 333
   Google Scholar
• Gitlin M. J., Weiner H., Fairbanks L., Hershman J. M., Friedfeld N. Failure of T3to potentiate tricyclic antidepressant response. Journal of Affective Disorders 1987; 1(3)267–272
   Google Scholar
• Glassman A. H., Platman S. R. Potentiation of a monoamine oxidase inhibitor by tryptophan. Journal of Psychiatric Research 1971; 7: 83–88
   Web of Science ®Google Scholar
• Glue P. W., Cowen P. J., Nutt D. J., Kolakowska T., Grahame-Smith D. G. The effect of lithium on 5-HT-mediated neuroendocrine responses and platelet 5-HT receptors. Psychopharmacology 1986; 90: 398–402
   PubMed Web of Science ®Google Scholar
• Goodwin F. K., Prange A. J., Post R. M., Muscettola G., Lipton M. A. Potentiation of antidepressant effects by L-Triiodothyronine in tricyclic non-responders. American Journal of Psychiatry 1982; 1(3)34–38
   Google Scholar
• Gray E. G. Severe depression: a patient's thoughts. British Journal of Psychiatry 1983; 14(3)319–322
   Google Scholar
• Hale A. S., Procter A. W., Bridges P. K. Clomipramine, tryptophan and lithium in combination for resistant endogenous depression: seven case studies. British Journal of Psychiatry 1987; 151: 213–217
   PubMed Web of Science ®Google Scholar
• Haskovec L, Rysanek K. The action of reserpine in imipramine-resistant depressive patients. Psychopharmacologia 1967; 1(1)18–30
   Google Scholar
• Heal D. J., Bristow L. J., Elliott J. M., Bloomfield J. G., Catto L. C., Atterwill C. K. The influence of L-triodothyrcine (T3) on the effects of repeated administration of desipramine or electroconvulsive shock on α2and β-adrenoceptor function in the brain of the rat: implications for the potentiation of antidepressant therapy by T3. Neuropharmacology 1987; 2(6)1131–1139
   Google Scholar
• Heninger G. R., Charney D. S., Sternberg D. E. Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression. Archives of General Psychiatry 1983; 40: 1335–1342
   PubMed Web of Science ®Google Scholar
• Hopkinson G, Kenny F. Treatment with reserpine of patient resistant to tricyclic antidepressants. Psychiatrica Clinica 1975; 8: 109–114
   PubMedGoogle Scholar
• Kendell R. E. The present status of electroconvulsive therapy. British Journal of Psychiatry 1981; 13(9)265–283
   Google Scholar
• Kline N. S., Sacks W. L. Treatment of depression with an MAOI inhibitor followed by 5-HTP-an unfinished research project. Acta Psychiatrica Scandinavica 1980; 280(Supplement.)233–241
   Google Scholar
• Kramlinger K. G., Post R. M. The addition of lithium to carbamazepine. Antidepressant efficacy in treatment-resistant depression. Archives of Geriatric Psychiatry 1989; 4(6)794–800
   Google Scholar
• Links P. S., Akiskal H. S. Chronic and intractable depressions: terminology, classification, and description of subtypes. Treating Resistant Depression, J Zohar, R. H. Belmaker. PMA Publishing Corp., New York 1987; 1–22
   Google Scholar
• Louie A. K., Meltzer H. Y. Lithium potentiation of antidepressant treatment. Journal of Clinical Psychopharmacology 1984; 4(6)316–321
   PubMed Web of Science ®Google Scholar
• Markowitz J., Brown R., Sweeny J., Mann J. J. Reduced length and cost of hospital stay for major depression in patients treated with ECT. American Journal of Psychiatry 1987; 14(4)1025–1029
   Google Scholar
• Medical Research Council. Clinical trial of the treatment of depressive illness. British Medical Journal 1965; 1: 881–886
   PubMed Web of Science ®Google Scholar
• Nierenberg A. A., Keck P. E. Management of monoamine oxidase inhibitor-associated insomnia with trazodone. Journal of Clinical Psychopharmacology 1989; 9: 42–45
   PubMed Web of Science ®Google Scholar
• Nolen W. A., van der Putte J. J., Dijken W. A., Kamp J. S. L-5-HTP in depression resistant to re-uptake inhibitors, An open comparative study with tranylcypromine. British Journal of Psychiatry 1985; 147: 16–22
   PubMed Web of Science ®Google Scholar
• Nolen W. A., van de Putte J. J., Dijken W. A., Kamp J. S., et al. Treatment strategy in depression. I. Non-tricyclic 2nd selective re-uptake inhibitors in resistant depression: a double-blind partial cross-over study on the effects of oxaprotiline and fluvoxamine. Acta Psychiatrica Scandinavica 1988a; 78: 668–675
   PubMed Web of Science ®Google Scholar
• Nolen W. A., van de Putte J. J., Dijken W. A., Kamp J. S. Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled cross-over studies with tranylcypramine versus L-5-hydroxytryptophan and nomifensine. Acta Psychiatrica Scandinavica 1988b; 7(8)676–683
   Google Scholar
• Osman O. T., Rudorfer M. V., Potter W. Z. Idazoxan: a selective alpha-2 antagonist and effective sustained antidepressant in two bipolar depressed patients. Archives of General Psychiatry 1990; 4(6)958–959
   Google Scholar
• Pare C. M. B. Potentiation of monoamine oxidase inhibitors by tryptophan. Lancet 1963; ii: 527–528
   Google Scholar
• Pare C. M. B. The present status of monoamine oxidase inhibitors. British Journal of Psychiatry 1985; 14(6)576–584
   Google Scholar
• Pare C. M. B., Kline N., Hallstrom C, Cooper T. B. Will amitriptyline prevent the “cheese” reaction of monoamine oxidase inhibitors. Lancet 1982; ii: 183–186
   Google Scholar
• Paykel E. S., Hale A. S. Recent advances in the treatment of depression. The Biology of Depression, J. F. W. Deakin. Gaskell Press, London 1986; 153–173
   Google Scholar
• Pope H. G., Jonas J. M., Hudson J. I., Kafka M. P. Toxic reactions to the combination of monoamine oxidase inhibitors and tryptophan. American Journal of Psychiatry 1985; 4(2)491–493
   Google Scholar
• Pope H. G., McElroy S. L., Nixon R. A. Possible synergism between fluoxetine and lithium in refractory depression. American Journal of Psychiatry 1988; 4(5)1292–1294
   Google Scholar
• Post R. M., Uhde T. W., Roy-Byrne P. P., Jaffe R. T. Antidepressant effect of carbamazepine. American Journal of Psychiatry 1986; 4(3)29–34
   Google Scholar
• Prange A. J., Wilson I. C., Rabon A. M., Lipton M. A. Enhancement of imipramine antidepressant activity by thyroid hormone. American Journal of Psychiatry 1969; 2(6)457–469
   Google Scholar
• Prange A. J., Loosen P. T., Wilson I. C., Lipton M. A. The therapeutic uses of hormones of the thyroid axis in depression. Neurology of Mood Disorders, R. M. Post, J. C. Ballinger. Williams & Wilkins, Baltimore, MD 1984; 311–322
   Google Scholar
• Prange A. J., Garbutt J. C., Loosen P. T. The hypothalamic-pituitary-thyroid axis in affective disorders. Psychopharmacology: the Third Generation of Progress, H. Y. Meltzer. Raven Press, New York 1987; 629–636
   Google Scholar
• Price L. H. Lithium augmentation in tricyclic resistant depression. Treatment of Tricyclic-Resistant Depression, I. L. Extein. American Psychiatric Press Inc., Washington 1989; 51–79
   Google Scholar
• Price L. H., Charney D. S., Heninger G. R. Variability of response to lithium augmentation in refractory depression. American Journal of Psychiatry 1986; 14(3)1387–1392
   Google Scholar
• Price L. H., Charney D. S., Heninger G. R. Reserpine augmentation of desipramine in refractory depression: clinical and neurobiological effects. Psychopharmacology 1987; 9(2)431–437
   Google Scholar
• Price L. H., Charney D. S., Heninger G. R. Efficacy of lithium-tranylcypromine treatment in refractory depression. American Journal of Psychiatry 1985; 14(2)619–623
   Google Scholar
• Price L. H., Cornwall T., Nelson J. C. Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression. American Journal of Psychiatry 1983; 140: 318–322
   PubMed Web of Science ®Google Scholar
• Price L. H., Charney D. S., Delgado P., Heninger G. R. Lithium treatment and serotonergic function: neuroendocrine and behavioural responses to intravenous tryptophan in affective disorder. Archives of General Psychiatry 1989; 4(6)13–19
   Google Scholar
• Quitkin F. M. The Importance of dosage in prescribing antidepressants. British Journal of Psychiatry 1985; 14(7)593–597
   Google Scholar
• Quitkin F. M., Rabkin J. G., Ross D., McGrath P. J. Duration of antidepressant treatment. Archives of General Psychiatry 1984; 4(1)238–245
   Google Scholar
• Quitkin F. M., McGrath P. J., Stewart J. W., Morrison W., Wagner S. G., Nunes E., Rabkin J. G., Tricamo E., Markowitz J., Klein D. F. Phenelzine and imipramine in mood reactive depressives. Archives of General Psychiatry 1989; 4(6)787–793
   Google Scholar
• Razani J., White K., White J., Simpson G, et al. The safety and efficacy of combined amitriptyline and tranylcypromine antidepressant treatment. Archives of General Psychiatry 1983; 40: 657–661
   PubMed Web of Science ®Google Scholar
• Sargant W. Combining the antidepressant drugs. Lancet 1963; ii: 1062
   Google Scholar
• Schmauss M., Laakman G., Dieterle D. Effects of α2-receptor blockade in addition to tricyclic antidepressants in therapy resistant depression. Journal of Clinical Psychopharmacology 1988; 8: 108–111
   PubMed Web of Science ®Google Scholar
• Schopf J., Baumann P., Lemarchand T., Rey M. Treatment of endogenous depression resistant to tricyclic antidepressants or related drugs by lithium addition. Results of a placebo-controlled double-blind study. Pharmacopsychiatry 1989; 2(2)183–187
   Google Scholar
• Schmauss M., Laakmann G., Dieterle D. Effects of α2-receptor blockade in addition to tricyclic antidepressants in therapy-resistant depression. Journal of Clinical Psychopharmacology 1988; 8: 108–111
   PubMed Web of Science ®Google Scholar
• Schrader G. D., Levine H. E. M. Response to sequential administration of clomipramine and lithium carbonate in treatment-resistant depression. British Journal of Psychiatry 1985; 14(7)573–575
   Google Scholar
• Sethna E. R. A study of refractory cases in depressive illnesses and their response to combined antidepressant treatment. British Journal of Psychiatry 1974; 12(4)265–272
   Google Scholar
• Simpson G. M., Lee J. H., Cuculicia A., Kellner R. Two dosages of imipramine in hospitalised endogenous and neurotic depressives. Archives of General Psychiatry 1976; 3(3)1093–1102
   Google Scholar
• Spiker D. G., Weiss J. C., Dealy R. S., Griffin S. J., Hanin I, et al. The pharmacologic treatment of delusional depression. American Journal of Psychiatry 1985; 142: 430–436
   PubMed Web of Science ®Google Scholar
• Steiner W, Fontaine R. Toxic reaction following the combined administration of fluoxetine and L-tryptophan: five case reports. Biological Psychiatry 1986; 2(1)1067–1071
   Google Scholar
• Thompson J., Rankin H., Ashcroft G. W., Yates C. M., McQueen J. K., Cummings S. W. The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo. Psychological Medicine 1982; 12: 741–751
   PubMed Web of Science ®Google Scholar
• van Praag H. M., van der Burg W., Bas E. R.H., Dols L. C. W. 5-Hydroxytryptophan in combination with clomipramine in ‘therapy-resistant’ depression. Psychopharmacology 1974; 3(8)267–269
   Google Scholar
• Vetulani J., Stawarz R. J., Dingell J. V., Sulser P. A possible common mechanism of action of antidepressant treatments. Reduction in sensitivity of noradrenergic cyclic AMP generating system in the rat limbic forebrain. Archives of Pharmacology 1976; 29(3)109–114
   Google Scholar
• Wager S. G., Klein D. F. Treatment refractory patients: affective disorders. Psychopharmacology Bulletin 1988; 24(1)69–74
   PubMedGoogle Scholar
• Wallinder J., Skott A., Carlsson A., Nagy A., Roos B-E. Potentiation of the antidepressant action of clomipramine by tryptophan. Archives of General Psychiatry 1976; 3(3)1384–1389
   Google Scholar
• Walinder J., Carlsson A., Persson R. 5-HT reuptake inhibitors plus tryptophan in endogenous depression. Acta Psychiatrica Scandinavica 1981; 6(3)179–190
   Google Scholar
• Watt D. C., Crammer J. C., Elkes A. Metabolism, anticholinergic effects and therapeutic effects on outcome of desmethylimipramine in depressive illness. Psychological Medicine 1972; 2: 397–405
   PubMed Web of Science ®Google Scholar
• White K, Simpson G. Combined MAOI-tricyclic antidepressant treatment: a re-evaluation. Journal of Clinical Psychopharmacology 1981; 7(5)264–282
   Google Scholar
• White K., Pistole T, Boyd J. L. Combined monoamine oxidase inhibitor-tricylic antidepressant treatment: a pilot study. American Journal of Psychiatry 1980; 13(7)1422–1425
   Google Scholar
• Young J. P. R., Lader M. H., Hughes W. C. Controlled trial of trimipramine, monoamine oxidase inhibitors and combined treatment in depressed outpatients. British Medical Journal 1979; 4: 1315–1317
   Google Scholar
• Zusky P. M., Biederman J., Rosenbaum J. F., Manschreck T. C., Gross O. C., Weidberg J. B., Gastifreid D. R. Adjunct low-dose lithium carbonate in treatment-resistant depression: a placebo-controlled study. Journal of Clinical Psychopharmacology 1988; 8: 120–124
   PubMed Web of Science ®Google Scholar